The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

Drug-eluting stent implantation in acute myocardial infarction. Do we need another randomised trial? (TYPHOON, PASSION and HORIZONS trials)

EuroInterv.2006;2:23-27.

Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
The goal of treatment of patients with acute myocardial infarction (AMI) is to achieve optimal and rapid restoration of coronary blood flow in the infarct-related vessel and to maintain the initial result at follow-up. There are two main treatment methods of re-opening an occluded artery: administrating a thrombolytic agent and primary percutaneous coronary intervention (PCI) with or without stenting. In the 1990s and the beginning of the 2000s, many randomized studies comparing these two reperfusion procedures have shown that primary PCI with routine stent implantation for AMI has a better outcome than thrombolytic therapy1,2 or balloon angioplasty3-5. A recent ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Left ventricular assist devices in cardiogenic shock and high-risk PCI